Naggie, Susanna <br/><br/>
Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals.  [electronic resource] 

 -  Gastroenterology  May 2012 
 - 1324-1334.e3 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review 
<br/><br/><label>ISSN: </label>1528-0012 
<br/><br/><label>Standard No.: </label>10.1053/j.gastro.2012.02.012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenine--analogs & derivatives<br/>Anti-HIV Agents--therapeutic use<br/>Antiviral Agents--adverse effects<br/>Coinfection<br/>Deoxycytidine--analogs & derivatives<br/>Dideoxynucleosides--therapeutic use<br/>Disease Progression<br/>Drug Administration Schedule<br/>Drug Interactions<br/>Drug Therapy, Combination<br/>Emtricitabine<br/>HIV Infections--drug therapy<br/>Hepatitis C, Chronic--drug therapy<br/>Homosexuality, Male<br/>Humans<br/>Interferon-alpha--therapeutic use<br/>Lamivudine--therapeutic use<br/>Liver Cirrhosis--virology<br/>Liver Diseases--prevention & control<br/>Male<br/>Oligopeptides--therapeutic use<br/>Organophosphonates--therapeutic use<br/>Polyethylene Glycols--therapeutic use<br/>Proline--analogs & derivatives<br/>Pyrrolidinones--therapeutic use<br/>Raltegravir Potassium<br/>Recombinant Proteins--therapeutic use<br/>Ribavirin--therapeutic use<br/>Serine Proteinase Inhibitors--therapeutic use<br/>Substance Abuse, Intravenous--complications<br/>Tenofovir<br/>Treatment Outcome